You don’t have the time to read all these e-mail alerts on topics from pharma business area? We are presenting a Pears Book eNewsletter – micro stories and mini case-studies just for your coffee-break.
You probably know the situation. Dozens of e-mails are arriving. These are not spam! You have chosen and requested receiving them yourself. Because you know that these topics are the ones that you “need” or “should” be interested in. But they end up in your inbox unopened and never read anyway. You simply do not have the time to read all of them. So you do not read anything. Sounds familiar? May we be of help to you?
Why should you read this newsletter and have a look at our blog at www.pearsbook.com?
I am wondering, why so many questions and questionmarks arise around ROI of e-projects. E-projects usually take about 3% of the whole marketing budget in pharma. All the other 97 % are spent and ROI is very rarely measured and questioned in these. Why to bother so much about ROI of e. Should not we start using it and see real resulst and impact in our target audience behaviour?